Researchers suggest effective COVID-19 screening within hemodialysis centers needs to include both RT-PCR and antibody testing to identify all patients requiring isolation.
In separate COVID-19 studies, investigators found that only some infected kidney transplant outpatients required hospitalization and patients on maintenance hemodialysis often have an atypical presentation of symptoms.
In a study, nonattendance of a hemodialysis session was significantly associated with higher mortality compared with attendance: 51.9 vs 4.86 per 100 patient-years.
In a study of dialysis patients with new-onset nonvalvular atrial fibrillation, investigators found a nearly 3-fold higher incidence of fatal or intracranial bleeding among patients who took apixaban compared with those who received no treatment.
